Diminished durability of chimeric antigen receptor T-cell efficacy with severe or prolonged postinfusion cytopenias

By rosaguerrero • June 16, 2022

Tabbara N, Sharp J, Gaut D, Pham TTD, Tang K, Oliai C, Sim MS, Schiller G, Young P, Sasine JP. Diminished durability of chimeric antigen receptor T-cell efficacy with severe or prolonged postinfusion cytopenias. Am J Hematol. 2022 Jul;97(7):E249-E255. doi: 10.1002/ajh.26551. Epub 2022 Apr 11. PMID: 35358346.

Tags: General Internal Medicine, Hematology/Oncology

Outpatient hospitalist-run procedure service bridges the gap in oncology care

Ghanem G, Tsai HHC, Durant C, Feigenbaum GS, Glaeser AM. Outpatient hospitalist-run procedure service bridges the gap in oncology care. Transfus Apher Sci. 2024 Apr[...]

Statewide Survey of Primary Care and Subspecialty Providers on Hepatocellular Carcinoma Risk-Stratification and Surveillance Practices

Moon AM, Swier RM, Lane LM, Barritt AS 4th, Sanoff HK, Olshan AF, Wheeler SB, Ioannou GN, Kim NJ, Hagan S, Vutien P, Benefield T,[...]

The PROMIS-16 reproduces the PROMIS-29 physical and mental health summary scores accurately in a probability-based internet panel

Hays RD, Herman PM, Rodriguez A, Slaughter M, Zeng C, Edelen MO. The PROMIS-16 reproduces the PROMIS-29 physical and mental health summary scores accurately in[...]